Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Published	Pages	Publisher	Report code
Oct 2022	53	Global Markets Direct	ASDR-611916

Published: Oct 2022 - Pages : 53 - Publisher : Global Markets Direct - Report code : ASDR-611916

Aurealis Therapeutics AG
ID Pharma Co Ltd
RemeGen Co Ltd
Ribomic Inc
Zucero Therapeutics Ltd